↓ Skip to main content

Multi-targeted prevention of cancer by sulforaphane

Overview of attention for article published in Cancer Letters, May 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 7,783)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
33 news outlets
blogs
4 blogs
twitter
14 X users
patent
4 patents
facebook
5 Facebook pages
wikipedia
1 Wikipedia page
googleplus
105 Google+ users
reddit
2 Redditors
video
5 YouTube creators

Readers on

mendeley
325 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Multi-targeted prevention of cancer by sulforaphane
Published in
Cancer Letters, May 2008
DOI 10.1016/j.canlet.2008.04.018
Pubmed ID
Authors
Abstract

Isothiocyanates are found in cruciferous vegetables such as broccoli, Brussels sprouts, cauliflower, and cabbage. Epidemiologic studies suggest that cruciferous vegetable intake may lower overall cancer risk, including colon and prostate cancer. Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables and is especially high in broccoli and broccoli sprouts. SFN has proved to be an effective chemoprotective agent in cell culture, carcinogen-induced and genetic animal cancer models, as well as in xenograft models of cancer. Early research focused on the "blocking activity" of SFN via Phase 2 enzyme induction, as well as inhibition of enzymes involved in carcinogen activation, but there has been growing interest in other mechanisms of chemoprotection by SFN. Recent studies suggest that SFN offers protection against tumor development during the "post-initiation" phase and mechanisms for suppression effects of SFN, including cell cycle arrest and apoptosis induction are of particular interest. In humans, a key factor in determining the efficacy of SFN as a chemoprevention agent is gaining an understanding of the metabolism, distribution and bioavailability of SFN and the factors that alter these parameters. This review discusses the established anti-cancer properties of SFN, with an emphasis on the possible chemoprevention mechanisms. The current status of SFN in human clinical trials also is included, with consideration of the chemistry, metabolism, absorption and factors influencing SFN bioavailability.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 325 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 3 <1%
Portugal 3 <1%
Malaysia 1 <1%
Japan 1 <1%
United Kingdom 1 <1%
France 1 <1%
Denmark 1 <1%
Canada 1 <1%
Unknown 313 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 45 14%
Student > Bachelor 43 13%
Researcher 42 13%
Student > Master 38 12%
Other 19 6%
Other 59 18%
Unknown 79 24%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 79 24%
Biochemistry, Genetics and Molecular Biology 44 14%
Medicine and Dentistry 38 12%
Chemistry 21 6%
Pharmacology, Toxicology and Pharmaceutical Science 14 4%
Other 41 13%
Unknown 88 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 387. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2026.
All research outputs
#100,181
of 34,307,719 outputs
Outputs from Cancer Letters
#5
of 7,783 outputs
Outputs of similar age
#132
of 140,011 outputs
Outputs of similar age from Cancer Letters
#1
of 84 outputs
Altmetric has tracked 34,307,719 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,783 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,011 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.